Nothing Special   »   [go: up one dir, main page]

Bourhill et al., 2018 - Google Patents

Going (reo) viral: Factors promoting successful reoviral oncolytic infection

Bourhill et al., 2018

View HTML
Document ID
18151174720292463942
Author
Bourhill T
Mori Y
Rancourt D
Shmulevitz M
Johnston R
Publication year
Publication venue
Viruses

External Links

Snippet

Oncolytic viruses show intriguing potential as cancer therapeutic agents. These viruses are capable of selectively targeting and killing cancerous cells while leaving healthy cells largely unaffected. The use of oncolytic viruses for cancer treatments in selected …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Bacteriophages

Similar Documents

Publication Publication Date Title
Müller et al. Past, present and future of oncolytic reovirus
Pietropaolo et al. Merkel cell polyomavirus and Merkel cell carcinoma
Choi et al. From benchtop to bedside: a review of oncolytic virotherapy
Marchini et al. Overcoming barriers in oncolytic virotherapy with HDAC inhibitors and immune checkpoint blockade
Bourhill et al. Going (reo) viral: Factors promoting successful reoviral oncolytic infection
Bretscher et al. H-1 parvovirus as a cancer-killing agent: past, present, and future
Moens et al. The role of Merkel cell polyomavirus and other human polyomaviruses in emerging hallmarks of cancer
Vähä-Koskela et al. Tumor restrictions to oncolytic virus
Mohamed et al. Potential for improving potency and specificity of reovirus oncolysis with next-generation reovirus variants
Kemp et al. Exploring reovirus plasticity for improving its use as oncolytic virus
Geisler et al. Coxsackievirus B3—its potential as an oncolytic virus
McCarthy et al. Developing picornaviruses for cancer therapy
Lypova et al. Targeting palbociclib-resistant estrogen receptor-positive breast cancer cells via oncolytic virotherapy
Liu et al. Development of group B coxsackievirus as an oncolytic virus: opportunities and challenges
He et al. Anti-tumor effects of an oncolytic adenovirus expressing hemagglutinin-neuraminidase of Newcastle disease virus in vitro and in vivo
Hong et al. Replication and spread of oncolytic herpes simplex virus in solid tumors
Hofman et al. The multifaceted role of macrophages in oncolytic virotherapy
Holbrook et al. Expanding the spectrum of pancreatic cancers responsive to vesicular stomatitis virus-based oncolytic virotherapy: challenges and solutions
Scheubeck et al. Starvation-induced differential virotherapy using an oncolytic measles vaccine virus
Ammour et al. The susceptibility of human melanoma cells to infection with the Leningrad-16 vaccine strain of measles virus
DeAntoneo et al. Reovirus activated cell death pathways
Yang et al. Molecular mechanisms of immune escape for foot-and-mouth disease virus
Malik et al. Piscine orthoreovirus (PRV)-3, but not PRV-2, cross-protects against PRV-1 and heart and skeletal muscle inflammation in Atlantic salmon
Ehrlich et al. Oncolytic virotherapy: the cancer cell side
Volovat et al. Oncolytic virotherapy: a new paradigm in cancer immunotherapy